Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies (U01 Clinical Trial Not Allowed)
Closed Posted
- Opportunity number
- RFA-AR-25-013
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.233 National Center on Sleep Disorders Research
- 93.837 Cardiovascular Diseases Research
- 93.838 Lung Diseases Research
- 93.839 Blood Diseases and Resources Research
- 93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- 93.867 Vision Research
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Non-501(c)(3) Nonprofits
- Special District Governments
- Tribal Governments (Federally Recognized)
- For Profit Organizations
- 501(c)(3) Nonprofits
- Higher Education Inst. (Private)
- Other
- Higher Education Inst. (Public)
- Public or Indian Housing Auth.
- County Governments
- Small Businesses
- State Governments
- Independent School Districts
- Tribal Organizations (Not Federally Recognized)
- City/Township Governments
- Points of contact
-
- NIH OER Webmaster grantsinfo@nih.gov
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is preparing to release a Notice of Funding Opportunity (NOFO) for the Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies. This limited competition cooperative agreement will solicit applications for continuing research on advancing the field of regenerative medicine using adult stem cells, leveraging remaining funds authorized through the 21st Century Cures Act. The grant is a U01 mechanism with clinical trials not allowed, targeting investigators who have previously been funded through the Regenerative Medicine Innovation Project. Potential applicants are encouraged to develop meaningful collaborations and responsive projects in preparation for the upcoming solicitation. The evaluation criteria will likely include assessments of scientific merit, experimental design, investigator qualifications, research environment, and alignment with program objectives. The anticipated due date for applications is December 9, 2025, though applications are not being solicited at this time.
While specific award values are not yet detailed, related NIH grant programs typically fund projects ranging from $30,000 to over $1 million, with project periods spanning 1-5 years. The funding opportunity is open to a diverse range of applicant types, including nonprofits, higher education institutions, tribal governments, for-profit organizations, and small businesses. Research will be conducted at the recipient's facilities, with a focus on innovative approaches to regenerative medicine using adult stem cells. The grant is part of a cooperative agreement, suggesting significant NIH program involvement and collaboration throughout the research process.
Synopsis
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies (U01 Clinical Trial Not Allowed)
Files
| File | Type | Posted |
|---|---|---|
| RFA-AR-25-013-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity